REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Anti-SARS-CoV-2 NP mAb #7 | This study | N/A |
Anti-SARS-CoV-2 NP mAb #9 | This study | N/A |
Anti-SARS-CoV-2 NP mAb #98 | This study | N/A |
Anti-His-tag mAb | MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. | Cat# D291-3;RRID: AB_10597733 |
Anti-DDDDK-tag (Flag) mAb | MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. | Cat#M185-3L; RRID: AB_11123930 |
SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody (7E1B) | Bioss Antibodies Inc. | Cat#bsm-41414M; RRID: AB_2848129 |
SARS coronavirus monoclonal antibody | BiosPacific, Inc. | Cat#A03070041P |
SARS coronavirus monoclonal antibody | BiosPacific, Inc. | Cat#A03080041P |
Anti-Mouse IgG, HRP-Linked F(ab’)2 Fragment Sheep | Cytiva | Cat#NA9310-1ML; RRID: AB_772193 |
Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 568 | Thermo Fisher Scientific | Cat#A-11031; RRID: AB_144696 |
Bacterial and virus strains | ||
SARS-CoV-2 isolate (2019-nCoV/JPN/TY/WK-521/2020) | National Institute of Infectious Diseases, Japan | N/A |
SARS-CoV-2 isolate (2019-nCoV/JPN/QHN001/2021) | National Institute of Infectious Diseases, Japan | N/A |
SARS-CoV-2 isolate (2019-nCoV/JPN/TY8-612/2021) | National Institute of Infectious Diseases, Japan | N/A |
SARS-CoV-2 isolate (2019-nCoV/JPN/TY7-501/2021) | National Institute of Infectious Diseases, Japan | N/A |
Human coronavirus OC43 | American Type Culture Collection (ATCC) | Cat#VR-1558 |
Human coronavirus 229E | American Type Culture Collection (ATCC) | Cat#VR-740 |
Human rhino virus 14 (HRV14) | American Type Culture Collection (ATCC) | Cat#VR-284 |
Human rhino virus 14 (HRV16) | American Type Culture Collection (ATCC) | Cat#VR-283 |
Respiratory syncytial virus (RSV) | American Type Culture Collection (ATCC) | Cat#VR-26 |
Influenza A virus (IFAV) H1N1 pdm09 isolate (A/Yokohama/72/2020) | Yokohama City Institute of Public Health, Kanagawa, Japan | N/A |
Influenza A virus (IFAV) H3N2 isolate (A/Yokohama/68/2020) | Yokohama City Institute of Public Health, Kanagawa, Japan | N/A |
Influenza B virus (IFBV) Victoria lineage isolate (B/Yokohama/33/2020) | Yokohama City Institute of Public Health, Kanagawa, Japan | N/A |
Influenza B virus (IFBV) Yamagata lineage isolate (B/Yokohama/35/2019) | Yokohama City Institute of Public Health, Kanagawa, Japan | N/A |
Chemicals, peptides, and recombinant proteins | ||
PrimeSTAR Mutagenesis Basal kit | Takara Bio Inc. | Cat#R046A |
WEPRO7240H Expression Kit | CellFree Sciences Co.,Ltd. | Cat#CFS-TRI-7240H |
WEPRO7240G Expression Kit | CellFree Sciences Co.,Ltd. | Cat#CFS-TRI-7240G |
Hi-QRAS Gel N | Kanto Chemical Co., Inc. | Cat#49902-58 |
Rapid CBB KANTO 3S | Kanto Chemical Co., Inc. | Cat#36533-79 |
His-tagged N-terminal deleted mutant of NP (ΔN-NP; 121-419) | This study | N/A |
Ni-Sepharose Fast Flow beads | Cytiva | Cat#17531801 |
PreScission Protease | Cytiva | Cat#27084301 |
ABTS Microwell Peroxidase Substrate (2-Component System) | Kirkegaard & Perry Laboratories | Cat#5120-0032 |
TMB 1-Component Microwell Peroxidase Substrate, SureBlue | Kirkegaard & Perry Laboratories | Cat#5120-0075 |
SuperSignal West Femto Maximum Sensitivity Substrate | Thermo Fisher Scientific | Cat#34095 |
Dulbecco’s modified Eagle’s medium (high glucose) | FUJIFILM Wako Pure Chemical Corporation | Cat#044-29765 |
CD hybridoma medium AGT medium | Thermo Fisher Scientific | Cat#12372025 |
HYGM-7 Express (Ready - to - use), Liquid, without Phenol Red, protein free | Kanto Chemical Co., Inc. | Cat#49432-50 |
Critical commercial assays | ||
Standard Q COVID-19 Ag | SD. Biosensor | Cat#Q-NCOV-01G |
Espline SARS-CoV-2 | Fujirebio | Cat#260319 |
Panbio COVID-19 Ag Rapid Test | Abbott | Cat#4571226475003 |
SARS-CoV-2 Rapid Antigen Test | Roche | Cat#508487 |
Deposited data | ||
Partial structure of SARS-CoV-2 NP-1 | Zinzula et al.24 | PDB: 6YUN |
Full-length structural model of MERS-NP | Yamaoka et al.21 | N/A |
Partial structure of SARS-CoV-2 NP-2 | Kang et al.23 | PDB: 6M3M |
Full-length structural model of SARS-CoV-2 NP | This study | https://doi.org/10.17632/7b67yg29d6.1 |
Multiple sequence alignment of SARS-CoV-2 NP | This study | https://doi.org/10.17632/7b67yg29d6.1 |
Experimental models: cell lines | ||
HCT-8 | American Type Culture Collection (ATCC) | CCL-244 |
MRC-5 | RIKEN BioResource Research Center | RCB0211 |
VeroE6/TMPRSS2 | Japanese Collection of Research Bioresources Cell Bank (JCRB) | JCRB1819 |
Oligonucleotides | ||
Reverse primer for the quantification of SARS-CoV-2: 5′- TGGCAGCTGT GTAGGTCAAC −3′ |
Shirato et al.42 | N/A |
Probe for the quantification of SARS-CoV-2: FAM-ATGTCGCGCATTGGCATGGA-BHQ | Shirato et al.42 | N/A |
Forward primer for the quantification of HCoV-229E: 5′- TTCCGACGT GCTCGAACTTT −3′ |
Vijgen et al.43 | N/A |
Reverse primer for the quantification of HCoV-229E: 5′- CCAACACGGTTG TGACAGTGA −3′ |
Vijgen et al.43 | N/A |
Probe for the quantification of HCoV-229E: FAM 5′- TCCTGAGGTCAATGCA −3′ TAMRA | Vijgen et al.43 | N/A |
Forward primer for the quantification of HCoV-OC43: 5′- ATGTTAGGCCGATA ATTGAGGACTAT −3′ |
Vijgen et al.43 | N/A |
Reverse primer for the quantification of HCoV-OC43: 5′- AATGTAAAGA TGGCCGCGTATT −3′ |
Vijgen et al.43 | N/A |
Probe for the quantification of HCoV-OC43: FAM 5′- CATACTCTGACGGTCACAAT −3′ TAMRA | Vijgen et al.43 | N/A |
Forward primer for the quantification of SARS-CoV-2: 5′- AAATTTTGGGG ACCAGGAAC −3′ |
Shirato et al.42 | N/A |
Software and algorithms | ||
ForteBio data analysis software | Fortebio | https://www.sartorius.com/en/products/protein-analysis/octet-systems-software |
MODELLER9.15 | Webb et al.44 | https://salilab.org/modeller/9.15/release.html |
Swiss PDB viewer 4.1 | Guex et al.45 | https://spdbv.vital-it.ch/ |
UCSF Chimera software 1.13.1 | Pettersen et al.46 | https://www.cgl.ucsf.edu/chimera/ |
MAFFT version 7 | Kato et al.47 | https://mafft.cbrc.jp/alignment/server/ |
MEGAX (MUSCLE) | Edgar et al.48, Kumar et al.49 | https://www.megasoftware.net/ |
Graphpad Prism 8.43 | Graphpad Software | https://www.graphpad.com/ |
Other | ||
Immunochromatographic assay with silver amplification technology | This study (FUJIFILM Corporation) | Cat#16696722 |